Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Montreal Cognitive Assessment (MoCA) XpressO: Validation of a Digital Self-administered Cognitive Pre-screening Tool for the General Adult Population

NCT05879562 is registered in ClinicalTrials.gov with MoCA Clinic and Institute as lead sponsor.

NCT NCT05879562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05879562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Montreal Cognitive Assessment (MoCA) XpressO: Validation of a Digital Self-administered Cognitive Pre-screening Tool for the General Adult Population
Lead sponsor
MoCA Clinic and Institute
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2022
Completion date
June 30, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

assessment, self, cognitive change, cognitive deficit, cognitive impairment